Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus (T2DM) and Concomitant Heart Failure

被引：0
|
作者：
Kosiborod, Mikhail
Gause-Nilsson, Ingrid Ami
Sonesson, Christian
Sugg, Jennifer E.
Johnsson, Eva
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1211-P
引用
收藏
页码：A313 / A313
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus and concomitant heart failure
    Kosiborod, M.
    Gause-Nilsson, I.
    Sonesson, C.
    Johnsson, E.
    [J]. DIABETOLOGIA, 2015, 58 : S368 - S368
  • [2] Efficacy and safety of dapagliflozin in patients with type 2 diabetes and concomitant heart failure
    Kosiborod, Mikhail
    Gause-Nilsson, Ingrid
    Xu, John
    Sonesson, Christian
    Johnsson, Eva
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (07) : 1215 - 1221
  • [3] Cardiovascular safety of dapagliflozin in type 2 diabetes mellitus (T2DM) patients with various degrees of cardiovascular risk
    Sonesson, C.
    Frederich, R.
    Johansson, P. A.
    Gause-Nilsson, I.
    Langkilde, A. M.
    List, J. F.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 1072 - 1072
  • [4] Efficacy and Safety of Ertugliflozin in Hispanic/Latino Patients (Pts) with Type 2 Diabetes Mellitus (T2DM)
    Liu, Jie
    Tarasenko, Lisa
    Ellison, Misoo C.
    Pong, Annpey
    Huyck, Susan
    Mancuso, James P.
    Terra, Steven G.
    Gantz, Ira
    [J]. DIABETES, 2019, 68
  • [5] Efficacy and Safety of Ertugliflozin across Racial Groups in Patients with Type 2 Diabetes Mellitus (T2DM)
    Liu, Jie
    Tarasenko, Lisa
    Pong, Annpey
    Huyck, Susan
    Wu, Larry
    Mancuso, James P.
    Terra, Steven
    Lauring, Brett
    [J]. DIABETES, 2018, 67
  • [6] SYSTEMATIC REVIEW OF COST EFFECTIVENESS OF DAPAGLIFLOZIN TREATING PATIENTS OF TYPE 2 DIABETES MELLITUS (T2DM)
    Hu, C.
    Zhang, C.
    Wang, B.
    Xu, L.
    [J]. VALUE IN HEALTH, 2018, 21 : S39 - S39
  • [7] EFFICACY AND SAFETY OF TREATMENTS OF TYPE 2 DIABETES MELLITUS (T2DM): A SYSTEMATIC REVIEW (SLR)
    Pettre, S.
    Selya-Hammer, C.
    Ho, S.
    Garg, M.
    Schroeder, M.
    Kaur, V
    Hemels, M.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A433 - A433
  • [8] Heart failure risk stratification and efficacy of dapagliflozin in patients with type 2 diabetes mellitus
    Berg, D.
    Wiviott, S.
    Scirica, B.
    Gurmu, Y.
    Mosenzon, O.
    Murphy, S.
    Bhatt, D.
    Leiter, L.
    McGuire, D.
    Wilding, J.
    Johansson, P.
    Langkilde, A.
    Raz, I.
    Braunwald, E.
    Sabatine, M.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 153 - 153
  • [9] Safety and Tolerability of Linagliptin and Metformin in Combination for Patients with Type 2 Diabetes Mellitus (T2DM)
    Ross, Stuart A.
    Haak, Thomas
    Patel, Sanjay
    Thiemann, Sandra
    Schumacher, Helmut
    Meinicke, Thomas
    [J]. DIABETES, 2014, 63 : A277 - A277
  • [10] DAPAGLIFLOZIN PHARMACOKINETICS IS SIMILAR BETWEEN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION WITH/WITHOUT T2DM AND T2DM PATIENTS WITHOUT HEART FAILURE.
    Melin, J.
    Parkinson, J.
    Hamren, B.
    Penland, R.
    Boulton, D.
    McMurray, J.
    Tang, W.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S71 - S71
12345